---
id: idsa-osteomyelitis-2024
title: "IDSA 2024 Clinical Practice Guideline: Diagnosis and Treatment of Osteomyelitis in Adults"
short_title: "IDSA Osteomyelitis 2024"

organization: Infectious Diseases Society of America
collaborators: null
country: US
url: https://www.idsociety.org/guidelines/
doi: null
pmid: null
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: IDSA GRADE
conditions:
  - osteomyelitis
  - bone infection
  - vertebral osteomyelitis
  - diabetic foot osteomyelitis
tags:
  - bone biopsy
  - IV antibiotics
  - surgical debridement
  - MRI
  - S. aureus

publication_date: 2024-04-01
previous_version_date: 2015-09-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 IDSA guideline update on the diagnosis and treatment of osteomyelitis in adults (native vertebral, contiguous/post-operative, and diabetic foot osteomyelitis).

## Key Recommendations

### Diagnosis
- **Clinical Suspicion**: Bone pain, localized warmth/swelling, overlying wound, systemic signs of infection (fever, elevated inflammatory markers).
- **Imaging**:
  - MRI: Most sensitive and specific for osteomyelitis.
  - X-ray: Initial test; may be normal early; look for periosteal reaction, bone destruction.
  - CT: Alternative if MRI contraindicated; useful for surgical planning.
  - Nuclear medicine (WBC scan, PET): Adjunct for difficult cases.
- **Microbiologic Diagnosis**: Bone biopsy with culture is gold standard. Obtain BEFORE antibiotics if feasible.
- Blood cultures (positive in ~50% of vertebral osteomyelitis).

### Pathogen-Directed Therapy (When Culture Available)
- Tailor antibiotics to culture and sensitivity.
- **S. aureus (MSSA)**: Nafcillin, cefazolin, or oxacillin.
- **S. aureus (MRSA)**: Vancomycin or daptomycin.
- **Streptococci**: Penicillin G or ceftriaxone.
- **Gram-Negative Bacilli**: Fluoroquinolone or cephalosporin based on sensitivity.

### Empiric Therapy
- Cover S. aureus (including MRSA if risk factors) and gram-negatives if polymicrobial suspected.

### Duration
- **Vertebral Osteomyelitis**: 6 weeks of IV antibiotics (may transition to oral with high bioavailability options if responding).
- **Long Bone Osteomyelitis**: 4-6 weeks IV.
- **Diabetic Foot Osteomyelitis**: 6 weeks if bone is not resected; shorter if all infected bone is surgically removed.

### Surgical Management
- Debridement of necrotic bone and hardware removal (if implant-associated) when feasible.
- Amputation may be necessary for extensive diabetic foot osteomyelitis.

### Oral Antibiotic Transition
- Highly bioavailable oral agents (fluoroquinolones, rifampin, linezolid, TMP-SMX, doxycycline) can be used after initial IV phase in select patients with good clinical response.
